Fangzhou at the Forefront of AI-Healthcare Push as China Issues Pharmaceutical Industry Digital Transformation Roadmap
GUANGZHOU, China, April 29, 2025 /PRNewswire/ -- Recently, seven Chinese regulatory bodies including the Ministry of Industry and Information Technology ("MIIT"), the National Health Commission, the Ministry of Commerce, and other key ministries jointly issued the 2025-2030 Pharmaceutical Industry Digital Transformation Implementation Plan ("Implementation Plan"). The new policy recognizes digital transformation...
United Imaging Healthcare Releases 2024 ESG Report, Driving Sustainable Development Through Innovation
SHANGHAI, April 29, 2025 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271) has released its 2024 Environmental, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. The report outlines continued progress in sustainability, compliance, and corporate responsibility, emphasizing how the company integrates long-term social value with global business growth. In 2024, the company achieved...
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) from February 2025 EU approval is based on the complete data set from...
E-Health Now CEO Kelly Xu won 2024 Forbes China Science and Technology Innovation Figures Award
BEIJING, April 28, 2025 /PRNewswire/ -- The Global Science and Technology Innovation Conference and the "2024 Forbes China Science and Technology Innovation Figures" Awards Ceremony, jointly hosted by the Anhui Provincial People's Government and the Global Science and Technology Innovation Alliance, was held grandly in Hefei, China in April 17-19, 2025. At this grand event focusing on "the...
Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing
New findings suggest 'BluePDRN™' offers a sustainable, scalable alternative to traditional animal-derived PDRNs SEOUL, South Korea, April 29, 2025 /PRNewswire/ -- Amorepacific revealed research findings confirming the skin-regenerative effects of polydeoxyribonucleotides (PDRNs) extracted from a microalgal source, Chlorella protothecoides. The findings were published in the international journal Archives of Dermatological Research under the title, "Effects of Chlorella...
Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025
SHANGHAI, April 29, 2025 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech specializing in developing innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies for cancer, today announced it will present preclinical data on a feeder-free manufacturing process for IL-2-independent TIL expansion at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), taking...
We need bold leadership to address complex social problems
SYDNEY, April 29, 2025 /PRNewswire/ -- Health Justice Australia is calling on the next government of Australia to show bold political leadership in addressing the complex challenges many people in our community experience. "More than ever, people in our community are facing interconnected health, social and justice issues that can have lifelong, intergenerational impacts on health and wellbeing....
AI Evolution and Life Sciences: Embracing New Frontiers at Dalton Venture CEO Summit 2025
HONG KONG, April 29, 2025 /PRNewswire/ -- Dalton Venture CEO Summit 2025 , jointly hosted by Dalton Venture and Hong Kong Science and Technology Parks Corporation (HKSTP), successfully concluded at Hong Kong Science Park. The summit brought together over 100 distinguished guests, including government officials, leading scholars, entrepreneurs, and investors from Mainland China, Hong Kong, and beyond, to...
Telix’s Illuccix PSMA-PET Imaging Agent Approved in France
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET imaging agent, Illuccix® (kit for the preparation of gallium-68...
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
BOSTON and ROLLE, Switzerland, April 29, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion of its ongoing collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to accelerate the deployment of MSK-ACCESS® powered with SOPHiA DDM™ globally. Building on the initial collaboration...
